Trial Profile
A Randomized, Open-Label, Single Dose, Crossover Study To Estimate The Relative Oral Bioavailability And Food Effect Of PF-03882845 In Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jun 2011
Price :
$35
*
At a glance
- Drugs PF 3882845 (Primary)
- Indications Diabetic nephropathies
- Focus Adverse reactions; Pharmacokinetics
- 09 Jun 2011 New trial record